Comparative effectiveness and safety of omalizumab and dupilumab in children with asthma

13/11/2024
16/02/2026
EU PAS number:
EUPAS1000000361
Study
Ongoing
Documents
Study protocol
Initial protocol
English (352.98 KB - PDF) View document
Study results
Study report
Other information